• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

IBU Arkansas coward

anonymous

Guest
Go ahead and get it pulled again but you know you are a poisonous, back stabbing coward.

Instead of doing the right thing, you cried like a baby to Stephanie and went full delay tactics simply because you are lazy and didn't want to interview.

Pull it if you want, but you are weak and toxic.

Yours is coming. Oh, it's coming.
 




Go ahead and get it pulled again but you know you are a poisonous, back stabbing coward.

Instead of doing the right thing, you cried like a baby to Stephanie and went full delay tactics simply because you are lazy and didn't want to interview.

Pull it if you want, but you are weak and toxic.

Yours is coming. Oh, it's coming.

sounds like the entire IBU and half of the new respiratory force